Stock Events

Stock Events

Relmada Therapeutics (RLMD) Q1 2025 Earnings

27MarConfirmed

Q2 2024

Q3 2024

Q4 2024

Q1 2025

-0.85

-0.76

-0.68

-0.59

Details

Expected EPS

-0.673333

Actual EPS

-0.62

Surprise EPS

0.05

Surprise Percent

+7.92%

Description

Relmada Therapeutics (RLMD) has reported earnings of -0.62 per share for Q1 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.